Page last updated: 2024-08-25

methotrexate and Facial Hemiatrophy

methotrexate has been researched along with Facial Hemiatrophy in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's2 (22.22)29.6817
2010's5 (55.56)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Bassi, A; Belloni Fortina, A; Bonamonte, D; Brazzelli, V; Cambiaghi, S; DI Lernia, V; Diociaiuti, A; El Hachem, M; Neri, I; Patrizi, A; Pepe, P; Schena, D; Virdi, A1
Chhabra, A; Lam, JM; Rhemus, W1
Anderson, LE; Knight, AM; Kreiger, PA; Licht, DJ; Treat, JR1
Gan, JJL; Iqbal, T; Koleva, E; Kuah, CY1
Benamara-Levy, M; Bodemer, C; Dionne, MC; Le Sache de Peufheiloux, L; Leducq, S; Maruani, A; Samimi, M1
Al Enezi, S; Al Khalaf, MK; Al Mutairi, MA; Zakkiriah, M1
Adapinar, B; Korkmaz, C; Uysal, S1
Tollefson, MM; Witman, PM1
Ball, WS; deGrauw, T; Goldberg-Stern, H; Passo, M1

Reviews

3 review(s) available for methotrexate and Facial Hemiatrophy

ArticleYear
Remission of seizures with immunosuppressive therapy in Parry-Romberg syndrome and en coup de sabre linear scleroderma: Case report and brief review of the literature.
    Pediatric dermatology, 2018, Volume: 35, Issue:6

    Topics: Brain; Child; Facial Hemiatrophy; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methotrexate; Remission Induction; Scleroderma, Localized; Seizures; Skin

2018
Treatments and outcomes in juvenile linear scleroderma: a narrative systematic review.
    European journal of dermatology : EJD, 2018, Oct-01, Volume: 28, Issue:5

    Topics: Facial Hemiatrophy; Humans; Immunosuppressive Agents; Methotrexate; Scleroderma, Localized; Steroids; Treatment Outcome; Ultraviolet Therapy

2018
Beneficial effect of immunosuppressive drugs on Parry-Romberg syndrome: a case report and review of the literature.
    Southern medical journal, 2005, Volume: 98, Issue:9

    Topics: Adult; Alopecia; Facial Hemiatrophy; Humans; Immunosuppressive Agents; Male; Methotrexate

2005

Other Studies

6 other study(ies) available for methotrexate and Facial Hemiatrophy

ArticleYear
A retrospective study on clinical subtypes and management of morphea in 10 Italian Dermatological Units.
    Italian journal of dermatology and venereology, 2021, Volume: 156, Issue:4

    Topics: Child; Child, Preschool; Facial Hemiatrophy; Humans; Italy; Methotrexate; Retrospective Studies; Scleroderma, Localized

2021
Tongue Involvement in Parry-Romberg Syndrome.
    The Journal of rheumatology, 2017, Volume: 44, Issue:9

    Topics: Adolescent; Atrophy; Child, Preschool; Disease Progression; Facial Hemiatrophy; Female; Glucocorticoids; Humans; Methotrexate; Prednisone; Tongue

2017
Parry-Romberg syndrome in a patient with scleroderma.
    BMJ case reports, 2018, Nov-14, Volume: 2018

    Topics: Dermatologic Agents; Facial Hemiatrophy; Female; Humans; Methotrexate; Middle Aged; Scleroderma, Localized

2018
Parry-Romberg syndrome in Kuwait. Neurological manifestations in 2 children.
    Saudi medical journal, 2019, Volume: 40, Issue:7

    Topics: Adolescent; Anticonvulsants; Atrophy; Cerebrum; Child; Electroencephalography; Epilepsies, Partial; Facial Hemiatrophy; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Ischemic Attack, Transient; Kuwait; Magnetic Resonance Imaging; Male; Methotrexate; Prednisolone

2019
En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients.
    Journal of the American Academy of Dermatology, 2007, Volume: 56, Issue:2

    Topics: Adolescent; Adult; Aged; Child; Dermatologic Agents; Disease Progression; Facial Hemiatrophy; Female; Humans; Male; Methotrexate; Middle Aged; Retrospective Studies; Scleroderma, Localized; Seizures

2007
Parry-Romberg syndrome: follow-up imaging during suppressive therapy.
    Neuroradiology, 1997, Volume: 39, Issue:12

    Topics: Brain; Child; Facial Hemiatrophy; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methotrexate; Prednisone

1997